Copyright © 2015 - 2022 Lifecarenews.in
LIFE CARE IS REGISTERED MAGAZINE IN RNI, NO.GUJGUJ/2015/71283
ProMIS Neurosciences Announces First Quarter 2023 Financial
Received FDA clearance for investigational new drug (IND)…
Sign in
Sign in
Recover your password.
A password will be e-mailed to you.
Browsing Tag
Neurosciences
ProMIS Neurosciences Announces Submission of
TORONTO, Ontario and CAMBRIDGE, Massachusetts, April 10, 2023…
ProMIS Neurosciences Announces Abstracts Accepted for
<!-- Name:DistributionId Value:8786631 -->
<!-- Name:EnableQuoteCarouselOnPnr Value:False -->
<!-- Name:IcbCode Value:4573 -->…
ProMIS Neurosciences Announces Full Year 2022 Financial
<!-- Name:DistributionId Value:8784609 -->
<!-- Name:EnableQuoteCarouselOnPnr Value:False -->
<!-- Name:IcbCode Value:4573 -->…
Minerva Neurosciences Announces Update on its New Drug
BURLINGTON, Mass., Dec. 28, 2022 (GLOBE NEWSWIRE) -- Minerva Neurosciences, Inc. (Nasdaq: NERV), a clinical-stage biopharmaceutical company focused on the development of therapies to treat central nervous system (CNS) disorders, today…